Literature DB >> 17070089

Testing the validity of the PDQ-39 in patients with MSA.

A Schrag1, C Jenkinson, C Selai, C Mathias, N Quinn.   

Abstract

We assessed the validity of the PDQ-39, a disease-specific health-related quality of life instrument for patients with Parkinson's disease, in patients with multiple system atrophy (MSA). Two hundred and seventy-nine patients completed the PDQ-39, the EQ-5D, the Hospital Anxiety and Depression Scale, and scales of life satisfaction and disease severity. Ceiling and floor effects were noted in some dimensions, and Mobility was skewed towards the severe end of the spectrum. Apart from the dimension of Social Support, all dimensions had high internal consistency. The factor structure of the PDQ-39 in MSA was stable, and convergent and divergent validity with other measures of quality of life and mental health were good. However, many of the specific features of MSA are not reflected in the PDQ-39. Higher order factor analysis did not support the use of a single summary index. We conclude that the PDQ-39 has only limited validity in patients with MSA.

Entities:  

Mesh:

Year:  2006        PMID: 17070089     DOI: 10.1016/j.parkreldis.2006.08.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  2 in total

1.  Considerations before initiating therapy in Parkinsonism: basing on the quality of life.

Authors:  Shu-Jin He; Zhen-Yang Liu; Yu-Jie Yang; Cong Shen; Yu-Jie Du; Xin-Yue Zhou; Jue Zhao; Yi-Min Sun; Ke Yang; Jian-Jun Wu; Feng-Tao Liu; Jian Wang
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

2.  Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.

Authors:  Juan-Juan Du; Tian Wang; Pei Huang; Shishuang Cui; Chao Gao; Yiqi Lin; Rao Fu; Haiyan Zhou; Shengdi Chen
Journal:  Brain Behav       Date:  2018-10-30       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.